PORTLAND, Ore., Nov. 16, 2015 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides diagnostic and testing services to healthcare insurers and physician groups, today announced that it will be presenting at the 8th annual LD Micro Main Event on Thursday, December 3rd at 9:00 AM PST / 12:00 PM EST. Doug Murphy-Chutorian, M.D., chief executive officer of Semler, will be giving the presentation. The presentation will be webcast live and may be accessed using this link: http://wsw.com/webcast/ldmicro9/smlr. The webcast will be archived for 90 days following the live presentation.
"We are very excited to have Semler Scientific present for the first time at the Main Event," commented Chris Lahiji, President of LD Micro.
The conference will be held at the Luxe Sunset Bel Air Hotel and will feature 230 companies in the small / micro-cap space.
About LD Micro
LD Micro is an investment newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published reports on select companies throughout the year. The firm also hosts the LD Micro Invitational in June. It is a non-registered investment advisor. For more information, please contact 408-457-1042 or visit www.ldmicro.com
About Semler Scientific, Inc.
Semler Scientific, Inc., is a company that provides diagnostic and testing services to healthcare insurers and physician groups. Its mission is to develop, manufacture and market innovative proprietary products and services that assist healthcare providers in evaluating and treating chronic diseases. The company's first patented and U.S. Food and Drug Administration, or FDA, cleared product, introduced commercially in 2011, measured arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease. In March 2015, the FDA granted 510(k) clearance for the next generation version of this product named QuantaFlo™, which was commercially launched in August 2015. In April 2015, the company launched its multi-test service offering, WellChec™, to more comprehensively evaluate patients for chronic disease. Additional information about Semler can be found at http://semlerscientific.com.
SOURCE Semler Scientific, Inc.